Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kalvista Pharmaceuticals Inc (NQ: KALV ) 11.78 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Kalvista Pharmaceuticals Inc < Previous 1 2 3 4 5 Next > KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 05, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Presents Real-World Data at the 2023 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology November 14, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Announces Phase 3 KONFIDENT Trial Milestone Achieved November 13, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals to Present at Upcoming Investor Conferences November 07, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 03, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals to Present Data at the 2023 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology November 02, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Presents Data on HAE Attacks in Patients Receiving Long-Term Prophylaxis at the Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2023 International Conference October 24, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 03, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals to Present at Cantor Global Healthcare Conference September 19, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Reports First Fiscal Quarter Results and Provides Operational Update September 07, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2023 HAEi Regional Conference EMEA August 28, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 02, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Expands Senior Leadership Team with Appointment of Nicole Sweeny as Chief Commercial Officer July 25, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Presents New HAE Attack Journey Data at 2023 US HAEA National Summit July 24, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2023 US HAEA National Summit July 14, 2023 From KalVista Pharmaceuticals Via Business Wire KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results July 07, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 05, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Presents New Data at 2023 Meeting of the European Academy of Allergy and Clinical Immunology June 12, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 05, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals to Present Data at the 2023 Meeting of the European Academy of Allergy and Clinical Immunology (EAACI) June 02, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals to Present at Jefferies Global Healthcare Conference May 31, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals to Present at Stifel 2023 Tailoring Genes: Genetic Medicines Day Virtual Conference May 23, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Presents Data at 13th C1-inhibitor Deficiency & Angioedema Workshop May 08, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 02, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals to Present Data at the 13th C1-inhibitor Deficiency & Angioedema Workshop April 27, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals to Present at 22nd Annual Needham Virtual Healthcare Conference April 12, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Reports Third Fiscal Quarter Results March 09, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Presents Data at American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting February 27, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals to Present Data at the 2023 American Academy of Allergy, Asthma & Immunology February 16, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire KalVista Pharmaceuticals Provides Progress Updates on Sebetralstat Development February 14, 2023 From KalVista Pharmaceuticals, Inc. Via Business Wire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.